Skip to main content
. 2023 Aug 29;95(1):79–91. doi: 10.3233/JAD-230350

Table 2.

Main effects (HR and 95% confidence intervals) of late-life hypertension status, BP variables, and FOXO3 rs2802292 longevity genotype, on risk of all-cause dementia, Alzheimer’s disease and vascular dementia

Model A All-cause dementia Alzheimer’s disease Vascular dementia
Variable HR (95% CI)1 p HR (95% CI) p HR (95% CI) p
HTN1 1.05 (0.89–1.25) 0.55 0.97 (0.79–1.18) 0.73 1.78 (1.05–2.99) 0.032
HTN2 1.02 (0.88–1.18) 0.79 0.96 (0.81–1.15) 0.67 1.76 (1.16–2.66) 0.0079
SBP ≥140 0.96 (0.83–1.13) 0.65 0.87 (0.73–1.05) 0.15 1.61 (1.03–2.54) 0.038
SBP ≥160 0.96 (0.82–1.13) 0.63 0.84 (0.69–1.02) 0.072 1.88 (1.26–2.79) 0.0018
DBP ≥90 0.96 (0.80–1.16) 0.68 0.89 (0.71–1.11) 0.30 1.50 (0.96–2.32) 0.074
DBP ≥95 0.73 (0.56–0.96) 0.023 0.65 (0.47–0.91) 0.011 1.53 (0.88–2.65) 0.13
FOXO3_G 0.88 (0.76–1.03) 0.10 0.87 (0.73–1.04) 0.12 0.77 (0.52–1.14) 0.19
Haplotype 0.89 (0.73–1.09) 0.25 0.87 (0.69–1.10) 0.26 0.86 (0.51–1.45) 0.57
Model B All-cause dementia Alzheimer’s disease Vascular dementia
Variable HR (95% CI)* p HR (95% CI) p HR (95% CI) p
HTN1 0.98 (0.82–1.18) 0.84 0.88 (0.71–1.09) 0.23 2.03 (1.11–3.69) 0.020
HTN2 0.93 (0.80–1.09) 0.39 0.88 (0.73–1.06) 0.19 1.71 (1.08–2.71) 0.022
SBP ≥140 0.92 (0.78–1.09) 0.33 0.83 (0.68–1.00) 0.051 1.74 (1.05–2.89) 0.032
SBP ≥160 0.89 (0.75–1.06) 0.20 0.77 (0.63–0.95) 0.015 1.80 (1.17–2.78) 0.0076
DBP ≥90 0.92 (0.75–1.12) 0.39 0.84 (0.67–1.07) 0.16 1.62 (1.00–2.62) 0.051
DBP ≥95 0.67 (0.50–0.90) 0.0073 0.59 (0.41–0.84) 0.004 1.57 (0.85–2.89) 0.15
FOXO3_G 0.88 (0.75–1.03) 0.099 0.87 (0.72–1.05) 0.14 0.75 (0.49–1.16) 0.19
Haplotype 0.87 (0.70–1.07) 0.19 0.85 (0.66–1.08) 0.19 0.84 (0.48–1.48) 0.56

Model A: HR (95% CI) were estimated from multivariate Cox models adjusted for baseline variables: age, education (years), CASI score, prevalent stroke, APOE ɛ4, and FOXO3_G (having the G-allele of FOXO3 SNP rs2802292, i.e., genotype TG or GG). Model B: HR (95% CI) were estimated from multivariate Cox models adjusted for baseline variables: age, education (years), APOE ɛ4, CASI score, BMI, plasma glucose, smoking (pack-year), alcohol drinking (ounces/month), physical activity index, and prevalent diabetes, CHD, stroke, and depressive symptoms. HTN1, SBP/DBP ≥140/90 mmHg or the self-reported use of anti-hypertensive medications; HTN2, SBP/DBP ≥160/95 mmHg or the self-reported use of anti-hypertensive medications; FOXO3_G, having the G allele of FOXO3 SNP rs2802292, i.e., genotype TG or GG.